TroostplekDe internet rustplaats

In memoriam · condoleanceregister

Étienne-Émile Baulieu

ook bekend als Étienne-Émile Baulieu

Geboren
12 december 1926
Overleden
30 mei 2025
Leeftijd
98 jaar
Rustplaatsen
Wetenschappers & uitvinders Bekende mensen, Frankrijk Landen

Biografie

Étienne-Émile Baulieu (French: [etjɛn emil boljø]; 12 December 1926 – 30 May 2025) was a French biochemist and endocrinologist who was best known for his research in the field of steroid hormones and their role in reproduction and aging. He has been nicknamed the “father” of the abortion pill mainly as a result of his work on the abortion-inducing drug RU486 (Mifepristone). Baulieu also worked to determine if dehydroepiandrosterone (DHEA) was a prohormone and if it and other hormonal substitutions also increased longevity in humans.

Early life and education

Baulieu was born Émile Blum to Jewish parents in Strasbourg, France, on 12 December 1926. His father, who died when Baulieu was four, was Léon Blum, a physician and an early specialist in diabetes. Baulieu changed his name during World War II when his family fled to the area near Grenoble and he engaged in the French resistance. After the war, he attended the Faculté de Médecine de Paris and became a physician in 1955. He studied further under his mentor Max Fernand Jayle (1913–1978) in the field of steroid hormones and obtained his PhD in 1963 at the Faculté de Médecine and Faculté des Sciences in Paris.

Career

In 1963 Baulieu was named a research director (equivalent to a research full professor) at INSERM, and in 1970 he became a professor of Biochemistry at the Faculty of Medicine of Bicêtre, affiliated with University of Paris-South. Since 2004, Baulieu was a member of the French "Ethical Advisory Committee" (Comité Consultatif National d'Ethique) for science and health. He was also associated with the "Institute of Longevity and Aging" (L'Institut de la longévité, des vieillesses et du vieillissement). In 2008, he started the Institut Baulieu, a research program to study and treat neurodegenerative diseases, and foster research into healthy longevity.

He served as president of the French Academy of Sciences and as a member of the United States' National Academy of Sciences.

Research

Baulieu had an ongoing interest in dehydroepiandrosterone (DHEA). In 1960 he demonstrated that DHEA was the main adrenal androgen, was largely conjugated as a hydrophilic sulfate, and described its metabolism and functions. He worked to uncover the production of estrogens by the placenta during pregnancy and this led to the concept of DHEA being a "prohormone". Upon the invitation of Seymour Lieberman, Baulieu became a visiting scientist at Columbia University in 1961–1962, and during this time he met Gregory Pincus, the father of the "birth control pill". Baulieu then turned to more studies in contraception and in the regulation of fertility and pregnancy. He became a pioneer in the description of intracellular sex steroid receptors and identified major intracellular participants such as the heat shock proteins. He worked on the progesterone receptor and androgen receptor. While steroid receptors are generally found within the cell, Baulieu identified a membrane receptor for a steroid hormone in Xenopus laevis.

Neurosteroids

Beginning in the late 1970s, Baulieu and Paul Robel with collaborators investigated the presence and metabolism of steroid hormones in the central nervous system. In a series of studies published between 1978 and 1981, they demonstrated that pregnenolone, dehydroepiandrosterone (DHEA), and related steroids are synthesized de novo in the brain, independently of peripheral endocrine glands. In 1981 Baulieu introduced the term “neurosteroids” to describe these endogenously produced steroids with potential neuromodulatory actions. During the early 1980s Baulieu’s group catalogued the distribution of neurosteroids in different brain regions and documented their variation across age, stress, and physiological states. At that time Baulieu emphasized that, although neurosteroids were clearly present in the nervous system, their physiological function remained unknown.

A major advance occurred in 1986, when Majewska, Harrison, and others reported that allopregnanolone and related neurosteroids are potent positive modulators of the GABAA receptor. This work provided the first molecular mechanism for neurosteroid action and established a direct link between Baulieu’s discovery of brain-derived steroids and inhibitory neurotransmission. Subsequent studies throughout the late 1980s and 1990s expanded the concept of neurosteroid modulation of GABAergic signaling and its relevance to stress, anxiety, seizure susceptibility, and mood regulation.

Baulieu continued to investigate the physiological and clinical significance of DHEA, pregnenolone, and their sulfate esters, including studies on aging, cognition, neuroprotection, and mood. In his 1997 reviews Baulieu summarized the state of knowledge regarding neuroactive neurosteroids.

In the early 21st century, the neurosteroid field developed into a translational research area in neuropsychopharmacology. Synthetic analogues of endogenous neurosteroids were developed as therapeutic agents, including ganaxolone for seizure disorders and zuranolone for postpartum depression and major depressive disorder. Additional neurosteroid-based or neurosteroid-inspired modulators of GABAA receptors have been explored in preclinical and clinical research.

RU486

Baulieu was known worldwide for his work on RU486 (Mifepristone) and has been termed the "father" of the abortion pill. Baulieu, who had identified the progesterone receptor, suggested to Roussel-Uclaf to modify the progesterone molecule to create an anti-progesterone. Georges Teutsch then synthesized an agent that became initially known as RU486 in 1980. Baulieu investigated the actions of this agent as an anti-progesterone steroid that proved to be able to induce early abortion, and became more effective in conjunction with misoprostol. As a proponent of a nonsurgical approach to abortion, Baulieu became an advocate for RU486 even when the company withdrew from the product and propelled him into the limelight of the abortion debate. As an anti-progesterone, RU486 also has other potential such as in the treatment of certain conditions (breast cancer, brain cancer, endometriosis, diabetes, hypertension), and the anti-cortisol activity he discovered may be useful to manage depression or Cushing's syndrome.

Longevity

Baulieu took increasing interest in what he called the "longevity revolution", that people are living longer, and its implications. As part of this, he investigated the potential of hormonal substitution such as DHEA to increase well-being in old age. The "Institute Baulieu" was started in 2008 to address issues that are detrimental to health in older people. One focus of research in the 2020s is finding ways to decrease the problems of the elderly to function independently.

Death

Baulieu died at his home in Paris, on 30 May 2025, at the age of 98.

Bron: Wikipedia, beschikbaar onder de licentie CC BY-SA 4.0.

In Memoriam weblink

en.wikipedia.org/wiki/%C3%89tienne-%C3%89mile_Baulieu

Foto's

Medeleven en bloemen 0

Het condoleanceregister van Étienne-Émile Baulieu: betuig hieronder uw medeleven aan de nabestaanden, leg een bloem of steek een kaars aan.

  • TroostplekSterkte aan alle nabestaanden.

Betuig als eerste uw medeleven of leg een bloem.

Uw medeleven of een bloem

Wat wilt u plaatsen?
Hoe lang is uw bericht?
Kies een bloem

Alle 27

Rouwkransen 4

Rouwboeketten 3

Klassiek 20

Hoe lang blijft uw bloem liggen?

Vaker een bloem leggen? Word lid: dan legt u zoveel bloemen als u wilt, en ze blijven allemaal voor altijd liggen. € 6,00 per maand of € 60,00 per jaar. Lid worden (met een gratis account)

0 / 500 tekens

Troostplek is een plek om te gedenken. Berichten worden eerst gelezen en daarna geplaatst; berichten die daar niet passen, verwijderen wij zonder uitleg.

Uw bloem voor altijd laten liggenEen langer medeleven plaatsen

€ 3,95€ 3,45 eenmalig

  • Uw bloem wordt nu gelegd en is meteen te zien.
  • Zodra uw betaling binnen is, blijft hij voor altijd liggen.
  • Lukt het betalen niet, dan blijft hij een maand liggen, zoals een gratis bloem.
  • Uw medeleven wordt nu geplaatst. Tot uw betaling binnen is, zijn alleen de eerste 500 tekens te lezen.
  • Zodra uw betaling binnen is, is de hele tekst te lezen.
  • Liever gratis? Ga terug en maak uw bericht korter dan 501 tekens.
Hoe wilt u betalen?

Bij crypto betaalt u de transactiekosten van het netwerk zelf, bovenop het bedrag. Bij iDEAL en een bankoverschrijving zijn er geen extra kosten.

Bij een bankoverschrijving of crypto ziet u na het plaatsen hoe u betaalt. Vul uw e-mailadres in om dat ook per mail te krijgen.

Vaker een bloem leggen? Als lid legt u zoveel bloemen als u wilt, voor altijd, vanaf € 6,00 per maand.Vaker een langer bericht? Als lid schrijft u zo lang als u wilt, gratis, vanaf € 6,00 per maand. Lid worden

Melden

Past dit bericht of deze bloem niet op Troostplek? Na uw melding is het niet meer te zien, tot wij ernaar hebben gekeken.

Meld een fout of aanvulling

Over het register van Étienne-Émile Baulieu. Vul in wat er anders moet; de rest mag leeg blijven.

Nu: Étienne-Émile Baulieu

Nu: 12 december 1926

Nu: 30 mei 2025

Nu: Wetenschappers & uitvinders